Thus, in this study, we aimed to evaluate the difference in expression of S100A8 in TCs and ICs between pre-invasive carcinoma and invasive carcinoma of the breast, and we investigated the clinicopathologic significance of its expression. Here, S100A8 is linked to invasive carcinoma.